A novel ARMS-based assay for the quantification of EGFR mutations in patients with lung adenocarcinoma

Quantification of epidermal growth factor receptor (EGFR) mutations is important for the prediction of tyrosine kinase inhibitor (TKI) efficacy in patients with non-small cell lung cancer (NSCLC). However, clinicians lack a sensitive and convenient method to quantify EGFR mutant abundance. The prese...

Full description

Saved in:
Bibliographic Details
Published in:Oncol Lett
Main Authors: Zhu, Yazhen, Guo, Zhiwei, Liu, Ying, Zheng, Xiyun, Yang, Guohua, Zheng, Guangjuan
Format: Artigo
Language:Inglês
Published: D.A. Spandidos 2018
Subjects:
Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5778799/
https://ncbi.nlm.nih.gov/pubmed/29435017
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.7679
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items